Alzheimer's Disease - From Fundamental Insights to Light at the End of the Translational Tunnel / Parkinson’s Disease: Genetics, Mechanisms and Therapeutics

Keystone Resort, Keystone, Colorado, U.S.A.

More than 200 researchers braved dizzying altitude, howling coyotes, and a fairly brooding mood in light of elusive trial success, to exchange the latest on Alzheimer's and Parkinson’s diseases in joint symposia held March 2-7 in Keystone, Colorado. Between plenary and parallel talks, bustling poster sessions, and the odd foray to the slopes, scientists discussed trial design, genetics, pathology, biomarkers, and cell and protein biology. Check back in the coming week as Alzforum posts highlights.

  1. Researchers Build on GWAS to Parse Genetic Players in AD and PD
  2. Prodromal Initiative to Identify Biomarkers for Parkinson’s
  3. Protecting Neurons by Ramping Up Waste Disposal?